Literature DB >> 18093595

Phosphorus levels are associated with subclinical atherosclerosis in the general population.

Stephen J Onufrak1, Antonio Bellasi, Leslee J Shaw, Charles A Herzog, Francesca Cardarelli, Peter W Wilson, Viola Vaccarino, Paolo Raggi.   

Abstract

BACKGROUND: Elevated serum phosphorus has been linked to mortality among patients with renal failure and in one study in the general population. The aim of our study was to examine the association of serum phosphorus level with carotid atherosclerosis in the general population.
METHODS: We determined the association of serum phosphorus levels with carotid intima-media thickness (cIMT) in 13,340 subjects 45-64 years old without known coronary heart disease, stroke, or renal disease from the Atherosclerosis Risk in Communities (ARIC) study.
RESULTS: Phosphorus levels were significantly associated with age, female gender, diabetes mellitus, hypertension, hypercholesterolemia and fibrinogen levels (p < 0.0001 for each), but not with estimated glomerular filtration rate (eGFR). Age- and sex-adjusted mean cIMT ranged from 0.718 to 0.736 mm for the lowest to the highest quintile of serum phosphorus (p-value for trend < 0.0001). This relationship was attenuated but remained statistically significant after adjustment for atherosclerotic risk factors and eGFR (trend p < 0.0001) in men but not in women. In a multivariable model, a one standard deviation increase in baseline serum phosphorus (0.48 mg/dL) was associated with a 0.012 mm increase in mean cIMT (p < 0.007) in men.
CONCLUSION: In a population-based cohort of subjects free of overt cardiovascular and renal disease serum phosphorus was positively associated with cIMT independent of traditional risk factors for atherosclerosis and eGFR in men but not in women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18093595     DOI: 10.1016/j.atherosclerosis.2007.11.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  46 in total

1.  Sequencing of 2 subclinical atherosclerosis candidate regions in 3669 individuals: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.

Authors:  Joshua C Bis; Charles C White; Nora Franceschini; Jennifer Brody; Xiaoling Zhang; Donna Muzny; Jireh Santibanez; Richard Gibbs; Xiaoming Liu; Honghuang Lin; Eric Boerwinkle; Bruce M Psaty; Kari E North; L Adrienne Cupples; Christopher J O'Donnell
Journal:  Circ Cardiovasc Genet       Date:  2014-06

2.  Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.

Authors:  Darbie Maccubbin; Diane Tipping; Olga Kuznetsova; William A Hanlon; Andrew G Bostom
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

3.  Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.

Authors:  Pieter Evenepoel; Björn Meijers; Liesbeth Viaene; Bert Bammens; Kathleen Claes; Dirk Kuypers; Dirk Vanderschueren; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

4.  Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment.

Authors:  Yao-Lung Liu; Chiu-Ching Huang; Chiz-Chung Chang; Che-Yi Chou; Shih-Yi Lin; I-Kuan Wang; Dennis Jine-Yuan Hsieh; Gwo-Ping Jong; Chih-Yang Huang; Chao-Min Wang
Journal:  Cardiorenal Med       Date:  2015-01-27       Impact factor: 2.041

5.  Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.

Authors:  Emilio González-Parra; Álvaro Aceña; Óscar Lorenzo; Nieves Tarín; María Luisa González-Casaus; Carmen Cristóbal; Ana Huelmos; Ignacio Mahíllo-Fernández; Ana María Pello; Rocío Carda; Ignacio Hernández-González; Joaquín Alonso; Fernando Rodríguez-Artalejo; Lorenzo López-Bescós; Alberto Ortiz; Jesús Egido; José Tuñón
Journal:  J Bone Miner Metab       Date:  2015-08-23       Impact factor: 2.626

6.  Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.

Authors:  Bhupesh Panwar; Suzanne E Judd; Virginia G Wadley; Nancy S Jenny; Virginia J Howard; Monika M Safford; Orlando M Gutiérrez
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

7.  Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality.

Authors:  Stephen J Onufrak; Antonio Bellasi; Francesca Cardarelli; Viola Vaccarino; Paul Muntner; Leslee J Shaw; Paolo Raggi
Journal:  Am J Epidemiol       Date:  2008-11-02       Impact factor: 4.897

8.  Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease.

Authors:  Lac Tran; Michael Batech; Connie M Rhee; Elani Streja; Kamyar Kalantar-Zadeh; Steven J Jacobsen; John J Sim
Journal:  Nephrol Dial Transplant       Date:  2015-08-08       Impact factor: 5.992

9.  An integrated understanding of the physiological response to elevated extracellular phosphate.

Authors:  Corinne E Camalier; Ming Yi; Li-Rong Yu; Brian L Hood; Kelly A Conrads; Young Jae Lee; Yiming Lin; Laura M Garneys; Gary F Bouloux; Matthew R Young; Timothy D Veenstra; Robert M Stephens; Nancy H Colburn; Thomas P Conrads; George R Beck
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

10.  Dietary phosphorus acutely impairs endothelial function.

Authors:  Emi Shuto; Yutaka Taketani; Rieko Tanaka; Nagakatsu Harada; Masashi Isshiki; Minako Sato; Kunitaka Nashiki; Kikuko Amo; Hironori Yamamoto; Yukihito Higashi; Yutaka Nakaya; Eiji Takeda
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.